Demand for Peripherally Inserted Central Catheter in Japan

Demand for Peripherally Inserted Central Catheter in Japan Forecast and Outlook (2025–2035)

The demand for peripherally inserted central catheters (PICC) in Japan is valued at USD 50.7 million in 2025 and is projected to reach USD 62.0 million by 2035, reflecting a compound annual growth rate (CAGR) of 2.0%. The growth in demand is primarily driven by the increasing prevalence of chronic conditions, such as cancer, that require long-term intravenous treatments. Additionally, the growing need for safer, minimally invasive vascular access procedures in hospitals and outpatient settings contributes to the rise in PICC adoption. The demand is further supported by advancements in catheter technology that enhance patient safety and reduce complications, making these devices a preferred option in clinical settings.

Over the forecast period, demand is expected to grow steadily, with incremental year-on-year increases. Starting at USD 45.9 million in earlier years, the market reaches USD 50.7 million in 2025 and continues to expand, reaching USD 62.0 million by 2035. The year-to-year growth is relatively stable, with incremental increases from USD 50.7 million in 2025 to USD 51.8 million in 2026, and progressing incrementally throughout the period. This steady growth reflects the ongoing need for PICCs in various medical treatments, particularly in Japan’s aging population, where these devices play a key role in long-term patient care.

Quick Stats of the Demand for Peripherally Inserted Central Catheters in Japan:

• Demand for Peripherally Inserted Central Catheters in Japan Value (2025): USD 50.7 million
• Demand for Peripherally Inserted Central Catheters in Japan Forecast Value (2035): USD 62.0 million
• Demand for Peripherally Inserted Central Catheters in Japan Forecast CAGR (2025 to 2035): 2.0%
• Leading Product Type by Demand: Conventional PICC (45%)
• Key Growth Regions for Peripherally Inserted Central Catheters: Kyushu & Okinawa, Kanto, Kinki, Chubu, Tohoku, Rest of Japan\
• Top Players in the Peripherally Inserted Central Catheter Industry in Japan: Becton, Dickinson and Company (BD), Cardinal Health Inc., Angio Dynamics, Inc., Teleflex Incorporated, Vygon Group

What is the Growth Forecast for Demand for Peripherally Inserted Central Catheter in Japan through 2035?

A major inflection point for the demand for peripherally inserted central catheters (PICC) in Japan takes place in the mid 2020s, around 2025. At that time demand crosses USD 50.7 million and begins accelerating as the healthcare system evolves. The combination of expanding outpatient infusion therapies, increased use in home and long term care settings, and institutional initiatives to shift from more invasive central venous access devices contributes to this shift. The value moves from USD 45.9 million in 2020 to USD 50.7 million in 2025, marking a transition from steady growth into a phase of stronger momentum.

A second inflection point occurs around 2030. Demand in Japan moves from approximately USD 55.0 million in 2030 to USD 62.0 million by 2035, reflecting increased adoption of PICC lines across oncology, parenteral nutrition, and complex infusion therapies. Training of specialist insertion teams, introduction of advanced PICC technologies (e.g., antimicrobial coatings, power injectables) and greater demand for long term intravenous access collectively drive this later surge. After this inflection the market enters a more mature stage, with growth increasingly led by device upgrades, higher complexity applications and replacement cycles rather than broad new volume expansion.

Peripherally Inserted Central Catheter Industry in Japan Key Takeaways

Metric	Value
Industry Value (2025)	USD 50.7 million
Forecast Value (2035)	USD 62.0 million
Forecast CAGR (2025 to 2035)	2.0%

What Is Driving the Demand for Peripherally Inserted Central Catheter in Japan?

The demand for peripherally inserted central catheters (PICC) in Japan is largely driven by the country’s aging population and the increasing prevalence of chronic conditions such as cancer, cardiovascular diseases, and infections, which often require long-term intravenous treatments. PICCs offer a safer and more comfortable alternative to traditional central venous catheters, especially for patients needing prolonged therapy. These devices are favored in both hospital and home healthcare settings because they reduce the frequency of needle insertions and provide stable venous access for extended periods. The growing emphasis on improving patient outcomes and comfort in Japan's healthcare system is contributing to the increased use of PICCs.

In addition to demographic trends, changes in healthcare delivery models are supporting the demand for PICCs. Japanese healthcare facilities are increasingly focusing on reducing hospital stays and enabling patients to continue treatment at home or in outpatient settings. This shift requires reliable and easy-to-manage solutions like PICCs that can be used for prolonged periods without causing discomfort or increasing the risk of complications. The country’s strong healthcare infrastructure and the availability of trained medical professionals further promote the adoption of PICCs, though challenges such as device-related complications and reimbursement concerns continue to affect the overall adoption rates.

What Factors Are Affecting the Demand for Peripherally Inserted Central Catheter in Japan in Terms of Product and Lumen?

The demand for peripherally inserted central catheters (PICC) in Japan is shaped by the type of product and the lumen configuration. The product types include conventional PICC, power injected PICC, and neonatal PICC, each designed for different patient needs. Lumen configurations include single lumen, double lumen, and multiple lumen, with each offering varying capabilities for the administration of fluids, medications, and other treatments. These segments reflect the growing need for flexible and efficient vascular access solutions in Japan, particularly in hospitals and healthcare settings that require advanced catheter options for long-term treatments.

What Drives the Leading Demand for Conventional PICC in Japan?

Conventional PICC accounts for 45% of the total demand in Japan. This product type is popular due to its versatility, ease of insertion, and suitability for a wide range of medical conditions requiring long-term venous access. Conventional PICC lines are commonly used for patients requiring prolonged intravenous therapies such as chemotherapy, antibiotics, and nutrition. The growing prevalence of chronic diseases, cancer treatments, and the need for long-term drug administration have led to the widespread adoption of conventional PICC lines across Japanese healthcare settings.

The demand for conventional PICC is also driven by its relatively lower cost compared to more specialized catheter types. As healthcare institutions in Japan look for reliable, cost-effective solutions for venous access, conventional PICC lines remain a preferred choice for treating patients requiring extended medical interventions. This continued preference, supported by its ease of use and the ability to deliver consistent, safe treatment, ensures its leading position in the market.

What Drives the Demand for Single Lumen PICC in Japan?

Single lumen PICC accounts for 52.0% of the total demand for peripherally inserted central catheters in Japan. This configuration is preferred for applications that require the infusion of a single substance at a time, such as antibiotics, nutrition, or chemotherapy. The demand for single lumen PICC is driven by its simplicity, cost-effectiveness, and efficiency in handling one treatment or infusion pathway at a time. These catheters are widely used for patients needing intravenous therapy for relatively straightforward medical conditions or temporary treatments.

The growing adoption of single lumen PICC is also attributed to the increasing number of procedures requiring vascular access for a limited duration. In Japan, where healthcare providers emphasize precise and efficient treatment protocols, the use of single lumen catheters ensures optimal control and safety during drug administration. As medical professionals seek practical, reliable solutions for intravenous therapy, the demand for single lumen PICC lines is expected to remain high.

What are the Key Trends, Growth Forces, and Barriers in the Demand for PICCs in Japan?

In Japan, demand for PICCs is gaining traction as the healthcare system adapts to rising numbers of patients requiring longterm intravenous therapies, including oncology, antibiotic administration and nutritional support. The ageing population, expansion of home care services and increasing preference for minimally invasive vascular access contribute to uptake. At the same time, barriers such as higher device cost, procedural training requirements and differing hospital adoption rates hinder uniform expansion across all regions. Understanding these factors is vital for companies and providers operating in the Japanese PICC segment.

What developments are encouraging increased use of PICCs in Japan?

The shift toward managing chronic conditions and delivering care outside of intensive inpatient settings is encouraging PICC adoption in Japan. As more patients receive chemotherapy, longterm antibiotics or parenteral nutrition, PICCs offer a reliable venous access option with potentially fewer insertions and lower complication risk compared to repeated peripheral IVs. Hospitals and outpatient centres are increasingly integrating protocols for PICC placement, making the device more common in Japan’s evolving care pathways.

What opportunities exist for PICC growth in Japan?

A clear opportunity in Japan lies in homebased infusion therapy and ambulatory care settings. With healthcare reimbursement models and institutional focus gradually shifting toward outpatient and home care, PICCs present a practical option for extended intravenous treatment outside the hospital. Device manufacturers and service providers can leverage this trend by offering PICC systems and support services tailored for home use, remote monitoring and patient education in Japan’s advanced healthcare environment.

What challenges may slow broader PICC adoption in Japan?

Despite positive dynamics, several challenges may restrain PICC uptake in Japan. Device cost and procedural overheads remain significant, especially when compared to simpler venous access methods. Insertion and maintenance of PICCs require trained staff, and the risk of complications such as infection or thrombosis may limit use in certain settings. Furthermore, reimbursement frameworks and institutional adoption may lag in some regional hospitals, leading to uneven penetration of PICC usage across Japan.

What is the Demand for Peripherally Inserted Central Catheter in Japan by Region?

Region	CAGR (%)
Kyushu & Okinawa	2.5%
Kanto	2.3%
Kinki	2.0%
Chubu	1.8%
Tohoku	1.6%
Rest of Japan	1.5%

The demand for peripherally inserted central catheters (PICC) in Japan is growing across regions, albeit at a moderate pace. Kyushu and Okinawa lead with a 2.5% CAGR, driven by increasing healthcare infrastructure and a demand for minimally invasive procedures. Kanto follows at 2.3%, influenced by its advanced medical facilities and higher healthcare utilization rates. Kinki records a 2.0% growth, supported by large hospitals and expanding adoption of PICC lines for patient care. Chubu grows at 1.8%, with steady use in regional healthcare systems. Tohoku reaches 1.6%, with gradual adoption in its medical centers. The rest of Japan shows a 1.5% growth, reflecting a slow but consistent demand for these devices in less populated areas.

How Is Kyushu & Okinawa Driving Demand for Peripherally Inserted Central Catheters?

Kyushu & Okinawa is projected to grow at a CAGR of 2.5% through 2035 in demand for peripherally inserted central catheters (PICC). The region’s growing healthcare infrastructure, especially in areas like Fukuoka, supports the demand for advanced medical devices. With an aging population and increasing chronic diseases, the need for long-term intravenous therapy is rising. The adoption of PICCs, known for their efficiency in providing long-term access to veins, helps improve patient outcomes and reduces complications. Additionally, healthcare initiatives aimed at improving patient care in the region continue to drive the demand for PICCs.

• Growing healthcare infrastructure in Fukuoka supports demand for PICCs.
• Aging population increases the need for long-term intravenous therapy.
• Chronic diseases fuel demand for efficient, long-term vein access solutions.
• Healthcare initiatives enhance the adoption of PICCs in medical facilities.

How Is Kanto Supporting Demand for Peripherally Inserted Central Catheters?

Kanto is projected to grow at a CAGR of 2.3% through 2035 in demand for peripherally inserted central catheters (PICC). As one of Japan’s most populous regions, Kanto, including Tokyo, sees significant adoption of PICCs in healthcare settings. The region’s advanced medical facilities are increasingly using PICCs for patients requiring long-term intravenous therapy, especially in oncology and intensive care units. The rising demand for minimally invasive procedures and the shift towards outpatient care further drive the use of PICCs as a safer, more efficient alternative to traditional central venous catheters.

• Advanced medical facilities in Tokyo drive PICC adoption.
• Rising demand for long-term intravenous therapy boosts PICC usage.
• Minimal invasive procedures increase preference for PICCs over traditional options.
• Shift towards outpatient care fuels demand for efficient intravenous access.

How Is Kinki Contributing to Demand for Peripherally Inserted Central Catheters?

Kinki is projected to grow at a CAGR of 2.0% through 2035 in demand for peripherally inserted central catheters (PICC). The region’s strong healthcare infrastructure, particularly in Osaka and Kyoto, supports the increasing use of PICCs in hospitals and clinics. As the elderly population grows, the demand for long-term intravenous therapies also rises. States like Osaka lead the way in implementing PICCs for chemotherapy, total parenteral nutrition, and other medical treatments requiring prolonged venous access. The adoption of PICCs continues to improve patient comfort and reduce risks associated with traditional catheter insertion methods.

• Strong healthcare infrastructure in Osaka and Kyoto drives PICC adoption.
• Elderly population increase fuels demand for long-term intravenous therapy.
• PICCs are preferred for chemotherapy and total parenteral nutrition.
• Adoption of PICCs improves patient comfort and reduces complications.

How Is Chubu Contributing to Demand for Peripherally Inserted Central Catheters?

Chubu is projected to grow at a CAGR of 1.8% through 2035 in demand for peripherally inserted central catheters (PICC). The region, with its focus on industrial healthcare and aging demographics, shows steady growth in PICC adoption. Cities like Nagoya, home to several hospitals and clinics, are leading the way in utilizing PICCs for efficient venous access. The increasing prevalence of chronic diseases such as cancer and diabetes, combined with the need for long-term intravenous therapy, continues to contribute to the demand for these advanced medical devices.

• Focus on industrial healthcare in Nagoya drives PICC adoption.
• Aging population and chronic disease prevalence increase PICC demand.
• Hospitals and clinics prioritize PICCs for long-term intravenous therapy.
• Efficient venous access drives steady adoption of PICCs in healthcare.

How Is Tohoku Supporting Demand for Peripherally Inserted Central Catheters?

Tohoku is projected to grow at a CAGR of 1.6% through 2035 in demand for peripherally inserted central catheters (PICC). The region’s healthcare sector, although less developed than other areas, is increasingly adopting PICCs in response to the growing elderly population and rising chronic diseases. With fewer healthcare facilities than larger regions, the demand for efficient and safe venous access solutions is significant. The region’s commitment to improving healthcare delivery, particularly in rural areas, further contributes to the growing adoption of PICCs for long-term intravenous therapies.

• Growing elderly population increases need for long-term intravenous access.
• Increasing chronic diseases drive demand for safe venous access solutions.
• Limited healthcare facilities boost demand for efficient PICC use.
• Regional focus on improving healthcare delivery supports PICC adoption.

How Is Rest of Japan Supporting Demand for Peripherally Inserted Central Catheters?

The Rest of Japan is projected to grow at a CAGR of 1.5% through 2035 in demand for peripherally inserted central catheters (PICC). Regions outside major urban areas are adopting PICCs for long-term venous access, particularly in rural and suburban healthcare facilities. As healthcare systems nationwide work to streamline intravenous therapy and improve patient care, the adoption of PICCs continues to rise. The Rest of Japan’s healthcare providers focus on improving efficiency and reducing the risks associated with traditional central venous access, contributing to the steady growth of the market.

• Rural and suburban areas increasingly adopt PICCs for venous access.
• Healthcare systems nationwide streamline intravenous therapy with PICCs.
• Focus on patient care efficiency boosts demand for PICCs in rural areas.
• Adoption of PICCs reduces risks compared to traditional central venous access.

What Is the Demand for Peripherally Inserted Central Catheter in Japan and Who Are the Key Players Shaping the Industry?

The demand for peripherally inserted central catheters (PICC) in Japan is driven by the country's aging population and the increasing prevalence of chronic conditions requiring long-term intravenous therapies. PICCs are preferred over traditional central venous catheters due to their lower complication rates, easier management, and ability to be used in outpatient settings. As hospitals in Japan strive to improve patient comfort while reducing infection risks, PICCs are becoming an essential component of vascular access solutions. The increased use of PICCs is also linked to advancements in insertion techniques and better training for healthcare providers, enabling their safe and effective use in a variety of medical conditions such as cancer, sepsis, and long-term nutrition therapy.

Key players shaping the market for PICCs in Japan include Becton, Dickinson and Company (BD), Cardinal Health Inc., AngioDynamics, Inc., Teleflex Incorporated, and Vygon Group. These companies offer a range of PICC products, including catheters, accessories, and insertion tools, which are designed to meet Japan's high standards for patient safety and clinical efficacy. BD leads with its Groshong® PICC series, providing users with a reliable, safe option for long-term vascular access. Teleflex, Cardinal Health, AngioDynamics, and Vygon offer various specialized PICCs that cater to different clinical needs, including specific catheter sizes, material types, and insertion systems. These companies are instrumental in expanding the use of PICCs in Japan’s healthcare system.

Key Players in Peripherally Inserted Central Catheter Industry in Japan

• Becton, Dickinson and Company (BD)
• Cardinal Health Inc.
• AngioDynamics, Inc.
• Teleflex Incorporated
• Vygon Group

Report Scope for Peripherally Inserted Central Catheter Industry in Japan

Items	Values
Quantitative Units (2025)	USD million
End Use	Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Centers
Product Type	Conventional PICC, Power Injected PICC, Neonatal PICC
Lumen Configuration	Single Lumen, Double Lumen, Multiple Lumen
Application	Chemotherapy, Long-term IV Infusion, Parenteral Nutrition, Blood Transfusion, Difficult Intravenous Access
Regions Covered	Kyushu & Okinawa, Kanto, Kinki, Chubu, Tohoku, Rest of Japan
Countries Covered	Japan
Key Companies Profiled	Becton, Dickinson and Company (BD), Cardinal Health Inc., AngioDynamics, Inc., Teleflex Incorporated, Vygon Group
Additional Attributes	Dollar by sales across product type, lumen configuration, and application sectors, healthcare provider adoption rates, patient demand for PICC devices, advancements in catheter insertion techniques, and reimbursement policies for long-term intravenous access.

Peripherally Inserted Central Catheter Industry in Japan Segmentation

Product:

• Conventional PICC
• Power Injected PICC
• Neonatal PICC

Lumen:

• Single Lumen
• Double Lumen
• Multiple Lumen

Application:

• Chemotherapy
• Long-term IV Infusion
• Parenteral Nutrition
• Blood Transfusion
• Difficult Intravenous Access

End User:

• Hospitals
• Cancer Research Institutes
• Long Term Care Centers
• Independent Infusion Centers
• Ambulatory Surgical Center

Region

• Kyushu & Okinawa
• Kanto
• Kinki
• Chubu
• Tohoku
• Rest of Japan